best glp-1 drug for weight loss Oral Medication Helps Patients Maintain | Newsroom GLP1 Drug Use For Weight

Nausea, vomiting, diarrhea, constipation, abdominal pain , and bloating show up regularly in trials and real-world use

Currently, Retatrutide is the only tri-agonist that has completed Phase II clinical trials [22]

Overall, adults ages 50 to 64 were most likely to have used GLP-1 drugs, but younger adults were more likely to use them solely for weight loss, according to the KFF survey

Cardiovascular Risks While some GLP-1 drugs improve heart health, patients with existing heart conditions require close monitoring

PMID: 26371721 Triplitt C, Chiquette E (2003): Exenatide: from the Gila monster to the pharmacy

Actual results may vary depending on benefit plan design, member demographics, programs implemented by the plan and other factors